Titel
A Phase II, randomized (1:1) open label study to assess the efficacy and safety of eltrombopag in combination with dexamethasone compared to dexamethasone, as first-line treatment in adult patients with newly diagnosed immune thrombocytopenia
Indikation
Primäre Immunthrombopenie
Art der Studie
Therapiestudie, Interventionell, Phase 2
Therapielinie
Erstlinientherapie
Hauptprüfer am Zentrum (PI)
Prof. Dr. med. M. Binder
Ansprechpartner
Frau S. Edemir
Telefon: 0345/ 557 3170
Mail: sabine.edemir@uk-halle.de